» Articles » PMID: 37999406

Marine Versus Non-Marine Bacterial Exopolysaccharides and Their Skincare Applications

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2023 Nov 24
PMID 37999406
Authors
Affiliations
Soon will be listed here.
Abstract

Bacteria are well-known to synthesize high molecular weight polysaccharides excreted in extracellular domain, which constitute their protective microenvironment. Several bacterial exopolysaccharides (EPS) are commercially available for skincare applications in cosmetic products due to their unique structural features, conferring valuable biological and/or textural properties. This review aims to give an overview of bacterial EPS, an important group of macromolecules used in cosmetics as actives and functional ingredients. For this purpose, the main chemical characteristics of EPS are firstly described, followed by the basics of the development of cosmetic ingredients. Then, a focus on EPS production, including upstream and downstream processes, is provided. The diversity of EPS used in the cosmetic industry, and more specifically of marine-derived EPS is highlighted. Marine bacteria isolated from extreme environments are known to produce EPS. However, their production processes are highly challenging due to high or low temperatures; yield must be improved to reach economically viable ingredients. The biological properties of marine-derived EPS are then reviewed, resulting in the highlight of the challenges in this field.

Citing Articles

Structure and Biosynthetic Gene Cluster of Sulfated Capsular Polysaccharide from the Marine Bacterium sp. KMM 8419.

Kokoulin M, Savicheva Y, Otstavnykh N, Kurilenko V, Meleshko D, Isaeva M Int J Mol Sci. 2024; 25(23).

PMID: 39684638 PMC: 11641403. DOI: 10.3390/ijms252312927.


Advances in Microbial Exopolysaccharides: Present and Future Applications.

Nguyen H, Pham T, Nguyen P, Le-Buanec H, Rabetafika H, Razafindralambo H Biomolecules. 2024; 14(9).

PMID: 39334928 PMC: 11430787. DOI: 10.3390/biom14091162.


Rhizosphere bacterial exopolysaccharides: composition, biosynthesis, and their potential applications.

Pham T, Nguyen T, Nguyen T, Pham M, Nguyen P, Nguyen T Arch Microbiol. 2024; 206(9):388.

PMID: 39196410 DOI: 10.1007/s00203-024-04113-1.


Exploring the Exopolysaccharide Production Potential of Bacterial Strains Isolated from Tunisian Blue Crab Microbiota.

Migaou M, Mace S, Maalej H, Marchand L, Bonnetot S, Noel C Molecules. 2024; 29(4).

PMID: 38398526 PMC: 10893132. DOI: 10.3390/molecules29040774.

References
1.
Colliec Jouault S, Chevolot L, Helley D, Ratiskol J, Bros A, Sinquin C . Characterization, chemical modifications and in vitro anticoagulant properties of an exopolysaccharide produced by Alteromonas infernus. Biochim Biophys Acta. 2001; 1528(2-3):141-51. DOI: 10.1016/s0304-4165(01)00185-4. View

2.
Perez S, Makshakova O, Angulo J, Bedini E, Bisio A, de Paz J . Glycosaminoglycans: What Remains To Be Deciphered?. JACS Au. 2023; 3(3):628-656. PMC: 10052243. DOI: 10.1021/jacsau.2c00569. View

3.
Almeida A, Sarmento B, Rodrigues F . Insights on in vitro models for safety and toxicity assessment of cosmetic ingredients. Int J Pharm. 2017; 519(1-2):178-185. DOI: 10.1016/j.ijpharm.2017.01.024. View

4.
Shu C, Yang S . Effects of temperature on cell growth and xanthan production in batch cultures of Xanthomonas campestris. Biotechnol Bioeng. 1990; 35(5):454-68. DOI: 10.1002/bit.260350503. View

5.
Drouillard S, Chambon R, Jeacomine I, Buon L, Boisset C, Courtois A . Structure of the Polysaccharide Secreted by CNCM I-5035 (Epidermist 4.0). Mar Drugs. 2020; 18(10). PMC: 7600630. DOI: 10.3390/md18100509. View